» Articles » PMID: 11041404

Scleromyxoedema-like Cutaneous Diseases in Renal-dialysis Patients

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2000 Oct 21
PMID 11041404
Citations 174
Authors
Affiliations
Soon will be listed here.
Abstract

15 renal dialysis patients have been identified with a skin condition characterised by thickening and hardening of the skin of the extremities and an increase in dermal fibroblast-like cells associated with collagen remodelling and mucin deposition. The disease closely resembles scleromyxoedema, yet has significant enough clinical and histopathological differences to warrant its designation as a new clinicopathological entity.

Citing Articles

Gadolinium-Based Contrast Agents (GBCAs) for MRI: A Benefit-Risk Balance Analysis from a Chemical, Biomedical, and Environmental Point of View.

Scarciglia A, Papi C, Romiti C, Leone A, Di Gregorio E, Ferrauto G Glob Chall. 2025; 9(3):2400269.

PMID: 40071223 PMC: 11891575. DOI: 10.1002/gch2.202400269.


The NSF Conundrum.

Kale H, Joshi A, Choorakuttil R, Thomas B, Antony A Indian J Radiol Imaging. 2024; 34(4):786-787.

PMID: 39318574 PMC: 11419739. DOI: 10.1055/s-0044-1782626.


The safety of magnetic resonance imaging contrast agents.

Cunningham A, Kirk M, Hong E, Yang J, Howard T, Brearley A Front Toxicol. 2024; 6:1376587.

PMID: 39188505 PMC: 11345262. DOI: 10.3389/ftox.2024.1376587.


Anthropogenic gadolinium in the Tone River (Japan): an update showing a 7.7-fold increase from 1996 to 2020.

Kumasaka S, Kartamihardja A, Kumasaka Y, Kameo S, Koyama H, Tsushima Y Eur Radiol Exp. 2024; 8(1):64.

PMID: 38782825 PMC: 11116359. DOI: 10.1186/s41747-024-00460-2.


Preclinical Safety Assessment of Gadopiclenol: A High-Relaxivity Macrocyclic Gadolinium-Based MRI Contrast Agent.

Gendron C, Bourrinet P, Dencausse A, Fretellier N Invest Radiol. 2023; 59(2):108-123.

PMID: 37921752 PMC: 11441737. DOI: 10.1097/RLI.0000000000001038.